SA446, a new orally active converting enzyme inhibitor: Antihypertensive action and comparison with captopril in stroke-prone spontaneously hypertensive rats
- 1 March 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 78 (4) , 411-420
- https://doi.org/10.1016/0014-2999(82)90483-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous systemThe American Journal of Cardiology, 1982
- Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captoprilEuropean Journal of Pharmacology, 1981
- Maintenance of blood pressure by the renin–angiotensin system in normal manNature, 1981
- Brain converting enzyme inhibition: A possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive ratsEuropean Journal of Pharmacology, 1981
- Antihypertensive Effects of the Novel Converting-Enzyme Inhibitor YS 980 in Spontaneously Hypertensive RatsClinical and Experimental Hypertension, 1981
- CaptoprilDrugs, 1980
- Induction of angiotensin I-converting enzyme in rat lung with captopril (SQ 14225)European Journal of Pharmacology, 1980
- Blood pressure responses of conscious normotensive and spontaneously hypertensive rats to intracerebroventricular and peripheral administration of captopril.Hypertension, 1980
- The central and peripheral effects of Captopril (SQ 14225) on the arterial pressure of the spontaneously hypertensive ratBrain Research, 1980
- Prevention of the development of spontaneous hypertension in rats by captopril (SQ 14,225)European Journal of Pharmacology, 1979